二期局麻下应用膀胱软镜处理复杂性肾结石经皮肾镜术后残石的研究

doi:10.3877/cma.j.issn.1674-3253.2024.01.013

目的

探讨二期局部麻醉下应用膀胱软镜处理复杂性肾结石微创经皮肾镜术后残石的临床疗效，评估其安全性和可行性。

方法

回顾性分析曲靖市第一人民医院2019年1月至2021年12月收治的二期手术治疗复杂性肾结石一期微创经皮肾镜术后残石患者的临床资料，按照手术方式的不同分为观察组（应用膀胱软镜组）56例和对照组（应用经皮肾硬镜组）38例，两组在年龄、性别、残留结石最大直径、位置以及数目等一般资料上比较差异无统计学意义（P>0.05）。比较两组在残石清除率、手术时间、术后24 h Hb下降量、术后24 h患者疼痛评分（VAS）、术后造瘘管留置根数、住院时间以及并发症发生情况方面的差异。

结果

在结石清除率方面：观察组为92.9%（52/56），对照组为94.7%（36/38），差异无统计学意义（P>0.05）；在手术时间、术后24 h Hb下降量、术后24 h患者疼痛评分（VAS）、术后造瘘管留置根数及住院时间方面观察组均优于对照组，差异有统计学意义（P<0.05）；在并发症发生情况方面：两组均无严重并发症发生，观察组并发症发生率为8.9%（5/56），对照组为23.7%（9/38），差异有统计学意义（P<0.05）。

结论

二期局麻下应用膀胱软镜处理复杂性肾结石微创经皮肾镜术后残石的方法安全且高效。

关键词: 复杂性肾结石, 经皮肾镜碎石取石术, 局部麻醉, 膀胱软镜

Objective

To investigate the clinical efficacy of using flexible cystoscope under secondary local anesthesia in the treatment of residual stone after minimally invasive percutaneous nephroscopy for complex kidney stones, and to evaluate its safety and feasibility.

Methods

Through retrospective analysis of the clinical data of patients with residual stones after one-stage minimally invasive percutaneous nephrolithotomy treated with complex renal stones in the First People’s Hospital of Qujing from January 2019 to December 2021, 56 patients were divided into observation group (the flexible cystoscope group) and control group (the percutaneous nephroscopy group) according to different surgical methods.There was no significant difference in age, sex, maximum diameter, location and number of residual stones between the two groups (P>0.05). The differences in residual stone removal rate, operative time, postoperative 24 h Hb decline, postoperative pain score (VAS), number of indent roots of postoperative fistula, length of hospital stay and incidence of complications were compared between the two groups.

Results

The calculi clearance rate was 92.9%(52/56) in the observation group and 94.7% (36/38) in the control group, with no significant difference (P>0.05). The observation group was superior to the control group in terms of operation time, postoperative 24 h Hb decline, postoperative pain score (VAS), postoperative catheter indentation number and hospital stay, with significant differences (P<0.05). In terms of the occurrence of complications: no serious complications occurred in the two groups, the incidence of complications was 8.9%(5/56) in the observation group and 23.7%(9/38) in the control group, with significant difference (P<0.05).

Conclusions

It is safe and effective to treat residual stone after minimally invasive percutaneous nephroscopy with bladder flexible cystoscope under local anesthesia.

Key words: Complex kidney stones, Percutaneous nephrolithotomy, Local anesthesia, Flexible cystoscope

表1 两组复杂性肾结石PCNL术后残石行二期手术患者术前临床资料对比

组别	例数	性别(例)		年龄[岁，(±s)]	残石直径[mm，(±s)]	残石位置(例)		残石数目(例)
组别	例数	男	女	年龄[岁，(±s)]	残石直径[mm，(±s)]	左侧	右侧	单发	多发
观察组	56	31	25	48±14	13±3	30	26	8	48
对照组	38	20	18	50±13	13±4	21	17	7	31
统计值		χ²=0.068		t=-0.665	t=-0.722	χ²=0.026		χ²=0.289
P值		0.795		0.508	0.472	0.872		0.591

表1 两组复杂性肾结石PCNL术后残石行二期手术患者术前临床资料对比

组别	例数	性别(例)		年龄[岁，(±s)]	残石直径[mm，(±s)]	残石位置(例)		残石数目(例)
组别	例数	男	女	年龄[岁，(±s)]	残石直径[mm，(±s)]	左侧	右侧	单发	多发
观察组	56	31	25	48±14	13±3	30	26	8	48
对照组	38	20	18	50±13	13±4	21	17	7	31
统计值		χ²=0.068		t=-0.665	t=-0.722	χ²=0.026		χ²=0.289
P值		0.795		0.508	0.472	0.872		0.591

表2 两组复杂性肾结石PCNL术后残石行二期手术患者手术相关资料对比

组别	例数	残石清除率(%)	手术时间[min，(±s)]	术后24 h Hb下降量[g/L，M(Q₁，Q₃)]	术后疼痛评分[VAS，(±s)]	肾造瘘管留置数（例）			住院时间[d，(±s)]
组别	例数	残石清除率(%)	手术时间[min，(±s)]	术后24 h Hb下降量[g/L，M(Q₁，Q₃)]	术后疼痛评分[VAS，(±s)]	0根	1根	2根	住院时间[d，(±s)]
观察组	56	92.9%	43±14	6.8(3.0，10.0)	2.7±1.4	16	40	0	2.7±1.4
对照组	38	94.7%	53±13	8.0(3.8，12.4)	5.1±1.5	0	37	1	4.9±1.3
统计值		χ²=0.134	t=-3.124	Z=-3.721	t=-7.880	χ²=14.190			t=-7.840
P值		0.714	0.002	<0.001	<0.001	<0.001			<0.001

表2 两组复杂性肾结石PCNL术后残石行二期手术患者手术相关资料对比

组别	例数	残石清除率(%)	手术时间[min，(±s)]	术后24 h Hb下降量[g/L，M(Q₁，Q₃)]	术后疼痛评分[VAS，(±s)]	肾造瘘管留置数（例）			住院时间[d，(±s)]
组别	例数	残石清除率(%)	手术时间[min，(±s)]	术后24 h Hb下降量[g/L，M(Q₁，Q₃)]	术后疼痛评分[VAS，(±s)]	0根	1根	2根	住院时间[d，(±s)]
观察组	56	92.9%	43±14	6.8(3.0，10.0)	2.7±1.4	16	40	0	2.7±1.4
对照组	38	94.7%	53±13	8.0(3.8，12.4)	5.1±1.5	0	37	1	4.9±1.3
统计值		χ²=0.134	t=-3.124	Z=-3.721	t=-7.880	χ²=14.190			t=-7.840
P值		0.714	0.002	<0.001	<0.001	<0.001			<0.001

表3 两组复杂性肾结石PCNL术后残石行二期手术患者并发症发生情况对比

组别	例数	发热例数	出血例数	发生率（%）
观察组	56	5	0	8.9
对照组	38	7	2	23.7
χ²值				3.889
P值				0.049

表3 两组复杂性肾结石PCNL术后残石行二期手术患者并发症发生情况对比

组别	例数	发热例数	出血例数	发生率（%）
观察组	56	5	0	8.9
对照组	38	7	2	23.7
χ²值				3.889
P值				0.049

[1]	Preminger GM, Assimos DG, Lingeman JE, et al. AUA nephrolithiasis Guideline panel). Chapter 1: AUA Guideline on management of staghorn calculi: diagnosis and treatment recommendations[J]. J Urol, 2005, 73(6): 1991-2000.
[2]	Chen Y, Feng J, Duan H, et al. Percutaneous nephrolithotomy versus open surgery for surgical treatment of patients with staghorn stones: a systematic review and meta-analysis[J]. PLoS One, 2019, 14(1): e0206810.
[3]	Türk C, Petřík A, Sarica K, et al. EAU Guidelines on interventional treatment for urolithiasis[J]. Eur Urol, 2016, 69(3): 475-482.
[4]	Kalkanli A, Cilesiz NC, Fikri O, et al. Impact of anterior kidney calyx involvement of complex stones on outcomes for patients undergoing percutaneous nephrolithotomy[J].Urol Int, 2020, 104(5-6): 459-464.
[5]	Aizezi X, Xie L, Xie H, et al. Epidemiological and clinical characteristics of stone composition: a single-center retrospective study[J]. Urolithiasis, 2022, 50(1): 37-46.
[6]	Zeng G, Mai Z, Xia S,et al. Prevalence of kidney stones in China: an ultrasonography based cross‐sectional study[J]. BJU Int, 2017, 120(1): 109-116.
[7]	Chewcharat A, Curhan G. Trends in the prevalence of kidney stones in the United States from 2007 to 2016[J]. Urolithiasis, 2021, 49(1): 27-39.
[8]	Jiao B, Ding Z, Luo Z, et al. Single-versus multiple-tract percutaneous nephrolithotomy in the surgical management of staghorn stones or complex caliceal calculi: a systematic review and meta-analysis[J]. Biomed Res Int, 2020, 2020: 8817070.
[9]	Degirmenci T, Bozkurt IH, Celik S, et al. Does leaving residual fragments after percutaneous nephrolithotomy in patients with positive stone culture and/or renal pelvic urine culture increase the risk of infectious complications[J]? Urolithiasis, 2019, 47(4): 371-375.
[10]	Eisner BH, Goldfarb DS. A nomogram for the prediction of kidney stone recurrence[J]. J Am Soc Nephrol, 2014, 25(12): 2685-2687.
[11]	El-Nahas AR, Khadgi S, Diab M, et al. Definition and unfavorable risk factors of trifecta in mini-percutaneous nephrolithotomy[J]. J Endourol. 2021, 35(8): 1140-1145.
[12]	Sahan A, Dincer E, Zkaptan O, et al. The impact of anterior calyceal stones on the outcomes of percutaneous nephrolithotomy for complex kidney stones: a comparative study[J]. Minerva Urol Nephrol, 2020, 73(6): 815-822.
[13]	Emmott AS, Brotherhood H, Paterson RF, et al. Complications, re-intervention rates and natural history of residual stone fragments following percutaneous nephrolithotomy[J]. J Endourol, 2018, 32(1): 28-32.
[14]	Balaji S, Ganpule A, Herrmann T, et al. Contemporary role of multi-tract percutaneous nephrolithotomy in the treatment of complex renal calculi[J]. Asian J Urol, 2020, 7(2): 102-109.
[15]	Seitz C, Desai M, Häcker A, et al. Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy[J]. Eur Urol, 2012, 61(1): 146-158.
[16]	万银绪，车吉忠，张永富, 等. 经皮肾镜联合软性膀胱镜治疗复杂性肾结石的临床分析[J]．中华泌尿外科杂志, 2014, 35(8): 579-582.
[17]	Zeng G, Cai C, Duan X, et al. Mini percutaneous nephrolithotomy is a noninferior modality to standard percutaneous nephrolithotomy for the management of 20-40 mm renal calculi: a multicenter randomized controlled Trial[J]. Eur Urol, 2021,79(1): 114-121.
[18]	Ahmad M, Mumtaz H, Hussain HU, et al. A prospective, single-centered, cohort study comparing the treatment of renal stones by following PCNL types: standard, tubeless & totally tubeless[J]. Ann Med Surg (Lond),2022,80:104325.
[19]	卫超, 张宇聪, 甘家骅, 等. 标准经皮肾镜取石术与无管化经皮肾镜取石术治疗肾结石的比较研究[J]. 中华泌尿外科杂志, 2018, 39(7): 532-536.
[20]	Bhat S, Lal J, Paul F. A randomized controlled study comparing the standard, tubeless, and totally tubeless percutaneous nephrolithotomy procedures for renal stones from a tertiary care hospital[J]. Indian J Urol, 2017, 33(4): 310-314.
[21]	Mao YH, Huang CP, Li TC, et al. Case selection and implementation of tubeless percutaneous nephrolithotomy[J]. Transl Androl Urol, 2021, 10(8): 3415-3422.

[1]	朱喆辰, 史京萍, 王鸣, 姚刚, 阮姝婕. 负压封闭引流联合局部浸润麻醉下清创并手术缝合修复胸部正中切口愈合不良的临床应用[J]. 中华损伤与修复杂志(电子版), 2021, 16(04): 316-321.
[2]	韩欣欣, 汪璐璐, 王子瑞, 赵辛, 王小竞. 局部麻醉药物在儿童口腔诊疗中的应用[J]. 中华口腔医学研究杂志(电子版), 2019, 13(01): 51-55.
[3]	孙文娟, 黄南楠, 唐倩, 杨雨虹. 上牙槽前、中神经阻滞麻醉技术在上颌牙周治疗中的应用[J]. 中华口腔医学研究杂志(电子版), 2015, 09(06): 470-473.
[4]	王琦, 陈新, 闵捷, 方露, 刘志奇, 孙伟, 于德新. 膀胱软镜镜检术中改良"Bag Squeeze"法的应用与疼痛焦虑影响因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 237-241.
[5]	武立新, 申广, 李龙, 陈冬. 膀胱穿刺局部麻醉预防膀胱侧壁肿瘤电切术中闭孔神经反射的效果观察[J]. 中华腔镜泌尿外科杂志(电子版), 2021, 15(04): 321-324.
[6]	谢汉平, 徐耀鹏, 文瀚东, 潘铁军. 机器人联合膀胱软镜治疗肾盂输尿管连接处狭窄合并继发性肾结石一例报告及文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(01): 61-63.
[7]	郑金华, 谢进东, 陈景宇, 黄永萍. 局麻联合强化麻醉下微创经皮肾镜术治疗上尿路结石的临床研究[J]. 中华腔镜泌尿外科杂志(电子版), 2019, 13(04): 263-266.
[8]	张文雪, 杨雪. 个性化护理干预对腹股沟疝患者术后生理心理指标的影响[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(02): 247-250.
[9]	王凡冰, 邓智超. 罗哌卡因和利多卡因在局麻下老年腹股沟疝手术中的应用研究[J]. 中华疝和腹壁外科杂志(电子版), 2020, 14(04): 388-391.
[10]	臧鸣, 孙程程, 王晶, 杨福全. 不同麻醉方式在腹股沟疝修补术后并发症及疼痛感受[J]. 中华疝和腹壁外科杂志(电子版), 2020, 14(03): 274-276.
[11]	荣长山, 汪平娟. 局部麻醉与硬膜外麻醉下自黏性补片应用于腹股沟疝修补术中的临床研究[J]. 中华疝和腹壁外科杂志(电子版), 2020, 14(02): 155-159.
[12]	彭泉, 王雷, 于华杰, 郑玉, 孔令环. 局部浸润麻醉在老年患者腹股沟疝修补术中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2018, 12(03): 223-225.
[13]	马学强, 刘翰林, 陈国平, 袁世超, 朱雄文. 局部麻醉下腹股沟疝腹膜前间隙Kugel补片无张力修补术的疗效[J]. 中华疝和腹壁外科杂志(电子版), 2018, 12(02): 139-141.
[14]	安春鸽, 王斐. 气管镜检查术前不同局部麻醉方法效果的观察与护理[J]. 中华肺部疾病杂志(电子版), 2017, 10(03): 346-347.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Study on the application of bladder flexible cystoscopy in the treatment of residual stones after percutaneous nephrolithotomy for complex renal calculi under local anesthesia

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Study on the application of bladder flexible cystoscopy in the treatment of residual stones after percutaneous nephrolithotomy for complex renal calculi under local anesthesia